A detailed history of Missouri Trust & Investment CO transactions in Amgen Inc stock. As of the latest transaction made, Missouri Trust & Investment CO holds 264 shares of AMGN stock, worth $75,350. This represents 0.02% of its overall portfolio holdings.

Number of Shares
264
Previous 237 11.39%
Holding current value
$75,350
Previous $76,000 10.53%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$258.78 - $328.31 $6,987 - $8,864
27 Added 11.39%
264 $68,000
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $3,068 - $3,461
12 Added 5.33%
237 $68,000
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $2,192 - $2,425
-10 Reduced 4.26%
225 $54,000
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $46,736 - $53,486
235 New
235 $53,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $153B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Missouri Trust & Investment CO Portfolio

Follow Missouri Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Missouri Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Missouri Trust & Investment CO with notifications on news.